22 November 2024

PRICE INQUIRY no. JODO/19/PR68772/2024 – being conducted as a market assessment study

In connection with the implementation of the project entitled “Development and introduction to the market of the first non-antibiotic product for the treatment of infectious eye diseases with an innovative ophthalmological composition in the form of eye drops, containing an active substance – povidone iodine” funded by the state budget from the Agency for Medical Research, Polpharma Pharmaceutical Works S.A, is requesting bids for to conduct a non-clinical study of pharmacodynamics and safety after repeated administration in an animal model of adaptive bacterial eye infection.

Details of the price inquiry can be found in the documents attached below.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.